G01N 2800/344
Disorders of the penis and the scrotum and erectile dysfuncrion
G01N2800/344 (Disorders of the penis and the scrotum and erectile dysfuncrion) appears on 4 US grants and 17 published applications in this corpus.
Search patents in G01N- Granted patents
- 4
- Published applications
- 17
- Assignees
- 7
- Inventors
- 39
- Latest grant
- 25 Jul 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 4 |
| 2003 | 0 | 1 |
| 2004 | 0 | 1 |
| 2005 | 1 | 0 |
| 2006 | 1 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 2 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 1 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 2 |
By publication year.
Recent patents
- Examination method for prediction of effect of treatment of cancer based on detection of cancer/testis antibodies25 Jul 2023US 11,709,165 B2Kawasaki Gakuen Educational Foundation
- Use of a neuregulin to treat peripheral nerve injury14 Jul 2015US 9,078,861 B2Acorda Therapeutics, Inc.
- Compounds for the treatment of sexual dysfunction31 Jan 2006US 6,991,916 B2Pfizer Inc.
- Compounds for the treatment of sexual dysfunction12 Apr 2005US 6,878,529 B2Pfizer Inc.
- Composition and method of treating hypogonadism in men6 Mar 2025US 2025/0073245 A1
- Method of treating hypogonadism in men6 Mar 2025US 2025/0073246 A1
- Method for examining therapeutic effect on cancer and composition for inducing immune response20 May 2021US 2021/0148927 A1Kawasaki Gakuen Educational Foundation
- Use of a Neuregulin to Treat Peripheral Nerve Injury1 Nov 2018US 2018/0311312 A1Acorda Therapeutics, Inc.
- Use of a Neuregulin to Treat Peripheral Nerve Injury6 Aug 2015US 2015/0216936 A1Acorda Therapeutics, Inc.
Most cited
By later US patents